Everyday Advocacy provides people living with endocrine and endocrine-related conditions with education, support, and tools ...

Dr Gillian Goddard, an endocrinologist and adjunct assistant professor at the New York University Grossman School of Medicine ...

Researchers have changed the name of PCOS (polycystic ovary syndrome) to PMOS (polyendocrine metabolic ovarian syndrome) to better reflect the condition's complex hormonal or endocrine disorder and to ...

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) ...

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) ...

Crinetics Pharmaceuticals (CRNX) is back in focus after announcing that new clinical data for PALSONIFY and investigational therapy atumelnant will be presented at ENDO 2026, highlighting ongoing work ...

Specialist in medical electrolysis and complex case management Marta Ivaskevych – on the psychosocial burden of hirsutism, ...

The moisturizer, sunscreen, or shampoo used in daily routines may contain dozens of plastic-associated chemicals linked to ...

Polycystic ovary syndrome has been renamed polyendocrine metabolic ovarian syndrome. The change reflects the biological ...

A New Drug Application for the investigational oral selective estrogen receptor degrader giredestrant has received Priority ...

Latest clinical data and research illustrate Regeneron’s advancement of innovative science for diverse and serious diseases with significant unmet needsTARRYTOWN, N.Y., June 04, 2026 (GLOBE NEWSWIRE) ...

Novel gedatolisib is currently under review at FDA for wild-type patients ...